At this point of the evolving RWD landscape, we thought it appropriate to begin to broadly assess the use of real world data.
Our survey is open now.
While the impact and legacy of the very much on-going pandemic most acutely hits those infected, their families and friends, and the frontline healthcare providers, one clear legacy of this extraordinary moment will be how it helped show real world data is a critical component of the life sciences industry’s future.
There is now a daily public consumption of complex, evolving real world health data to an extraordinary degree. From the original goal of “flattening the curve” to rolling averages, and rates for testing, cases, hospitalizations, deaths, vaccinations and more, data inserts itself into the daily discourse up, down, and across society. At the same time, real world data continues to increasingly impact virtually every facet of what the life sciences industry does - from R&D strategy to commercialization – across therapeutic areas.
Again, your support of our survey is appreciated.
FDA Approves Roche’s Susvimo Refillable Eye Implant for Diabetic Macular Edema
February 4th 2025Roche’s Susvimo, a refillable eye implant for diabetic macular edema, provides continuous delivery of ranibizumab, showing sustained vision improvements with fewer treatments than standard eye injections.
The Future of Fertility: AI, Personalized Medicine, and Ethical Considerations
January 30th 2025Dr. Lawrence B. Werlin, MD, FACOG of HRC Fertility (@md.lawrence.werlin on TikTok), discusses how to combat the spread of misinformation on social media, opportunities that social media presents, advancements in fertility technology, and more.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.